Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted by Forrester, Audrey et al.
JOURNAL OF VIROLOGY, Jan. 1992, p. 341-348
0022-538X/92/010341-08$02.00/0
Copyright C 1992, American Society for Microbiology
Construction and Properties of a Mutant of Herpes Simplex Virus
Type 1 with Glycoprotein H Coding Sequences Deleted
AUDREY FORRESTER,' HELEN FARRELL,' GAVIN WILKINSON,2 JANE KAYE,'
NICHOLAS DAVIS-POYNTER,' AND TONY MINSON1*
Division of Virology, Department of Pathology, University of Cambridge, Tennis Court Road,
Cambridge CB2 IQP,1 and PHLS Center for Applied Microbiology and Research,
Porton Down, Salisbury, Wiltshire SP4 OJG,2 United Kingdom
Received 30 July 1991/Accepted 2 October 1991
A mutant of herpes simplex virus type 1 (HSV-1) in which glycoprotein H (gH) coding sequences were deleted
and replaced by the Escherichia coli lacZ gene under the control of the human cytomegalovirus IE-1 gene
promoter was constructed. The mutant was propagated in Vero cells which contained multiple copies of the
HSV-1 gH gene under the control of the HSV-1 gD promoter and which therefore provide gH in trans following
HSV-1 infection. Phenotypically gH-negative virions were obtained by a single growth cycle in Vero cells. These
virions were noninfectious, as judged by plaque assay and by expression of I-galactosidase following
high-multiplicity infection, but partial recovery of infectivity was achieved by using the fusogenic agent
polyethylene glycol. Adsorption of gH-negative virions to cells blocked the adsorption of superinfecting
wild-type virus, a result in contrast to that obtained with gD-negative virions (D. C. Johnson and M. W. Ligas,
J. Virol. 62:4605-4612, 1988). The simplest conclusion is that gH is required for membrane fusion but not for
receptor binding, a conclusion consistent with the conservation of gH in all herpesviruses.
The diversity of the herpesviruses is amply illustrated by
the variety of the surface glycoproteins specified by different
members of the group. All herpesviruses specify multiple
surface glycoproteins, but only two, represented by glyco-
protein B (gB) and gH of herpes simplex virus (HSV), are
found in herpesviruses of all subgroups (2, 8, 9, 20, 22, 36,
41). gB and its homologs have been studied extensively. The
amino acid sequence is relatively well conserved among
different herpesviruses, and studies with temperature-sensi-
tive mutants, antibody-resistant mutants, and gB null mu-
tants show that gB functions in viral entry into the host cell
(4, 5, 10, 23, 33, 44). These studies all suggest that gB
operates in membrane fusion rather than virus adsorption, a
view supported by the fact that mutations in gB can influence
the syncytial phenotype (3, 5); however, studies of the
interaction of viral glycoproteins with the cell surface, done
with HSV and pseudorabies virus, suggest that gB may also
be involved in the adsorption process (27, 30, 38). The
current view is that gB is certainly required for membrane
fusion but may additionally participate in virus adsorption to
the plasma membrane.
By contrast, gH has been the subject of few studies. The
facts that a temperature-sensitive (ts) mutation has been
identified in HSV type 1 (HSV-1) gH (7, 11) and that
antibody to gH efficiently neutralizes virion infectivity in the
absence of complement (1) suggest that gH is essential for
virion infectivity. In addition, gH antibodies will inhibit
membrane fusion by syncytial virus strains (20), and virus
particles treated with anti-gH antibodies will bind to cells but
will not penetrate (17). Data for gH of other herpesviruses
are very limited. The amino acid sequences of gH homologs
are poorly conserved, homology being limited to the C-ter-
minal portion of the extracellular domain (19), and the view
that gH homologs have conserved function is based on the
observations that antibodies against these homologs have
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similar biological effects on their respective viruses (28, 42,
48).
Thus, the available data suggest that gH, like gB, is
required for virion entry into the host cell, that its function is
common to all herpesviruses, and that gH operates in
membrane fusion, but the data are few and the evidence is
indirect. In an attempt to obtain more direct evidence, we
decided to produce an HSV-1 mutant in which the gH coding
sequences were deleted. This article describes the construc-
tion and properties of such a mutant.
MATERIALS AND METHODS
Cells and viruses. Vero cells were grown in Glasgow's
modified Eagle's medium (GMEM) containing 10% newborn
calf serum. BHK-21 cells and BU-BHK cells (TK-, bro-
modeoxyuridine-resistant BHK cells) were maintained in the
same medium supplemented with 10% tryptose phosphate
broth. VD60 cells, a cell line derived from Vero and able to
supply HSV-1 gD in trans (32), were a gift from D. C.
Johnson (McMaster University, Hamilton, Ontario, Canada)
and were maintained in GMEM lacking histidine and sup-
plemented with 1.0 mM histidinol and 7% fetal calf serum.
The following viruses were used: HSV-2 strain 25766;
HSV-1 strains HFEM, SC16, KOS, and tsQ26 (a ts mutant
derived from KOS, containing a lesion in the gH coding
sequence) (7, 11). TKDM21 is a thymidine kinase deletion
mutant derived from SC16 (12). All virus stocks were grown
at a multiplicity of infection (MOI) of 0.01 in BHK-21 cells
and were assayed in BHK-21 cells. FgD-,B is a gD-negative
virus (32) and was a gift from D. C. Johnson. The virus was
propagated and assayed in VD60 cells. Phenotypically gD-
negative virions were obtained by a single passage at an MOI
of 3 in Vero cells. Unadsorbed input virus was removed by
adding neutralizing monoclonal antibody LP2 (39) at a final
concentration of 30 ,ug/ml for 1 h at 37°C at the end of the
adsorption period.
Plasmids. pAF2 contains the HSV-1 (HFEM) gH coding
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sequence within the vector sp64T. This vector provides
flanking sequences corresponding to the 5' and 3' untrans-
lated sequences of the Xenopus p-globulin transcript. The
construction of pAF2 has been described (21). Plasmid
pgDBr (13, 14) contains the HSV-1 gD promoter (-392 to
+11). pSV2Neo (47) contains the G418 resistance marker
under the control of the simian virus 40 early promoter.
Plasmid pMV10 is derived from pUC18 and contains a
HindlIl insert composed of the Escherichia coli lacZ coding
sequence flanked by the cytomegalovirus (CMV) IE-1 pro-
moter and poly(A) addition site. Flanking sequences on the
5' side correspond to nucleotides -299 to +69 with respect
to the IE-1 transcript start site and on the 3' side correspond
to nucleotides +2757 to +3053. The construction of pMV10
will be described elsewhere.
Transfection. Transfection of Vero cells or BHK-21 cells
was performed on subconfluent monolayers by the modified
calcium phosphate procedure of Chen and Okayama (6).
When the objective was to produce a stably transfected cell
line, the cells were grown in 25-cm2 flasks and transfected
with 15 ,ug of plasmid carrying the selectable marker
(pSV2Neo) and 15 pg of nonselected plasmid. The trans-
fected cells were harvested after 48 h and replated in medium
containing G418 (400 jig/ml). Surviving colonies were har-
vested and cloned by limiting dilution in the presence of
G418.
When the objective was to construct recombinant viruses
carrying the lacZ gene, similar monolayers were transfected
with 20 jig of HSV-1-infected cell DNA plus 5 pLg of plasmid
DNA carrying the desired sequences for recombination.
After 3 days, the cells, which exhibited extensive cytopathic
effect, were harvested and sonicated. The number of prog-
eny and the proportion of recombinant P-galactosidase-
positive virus were then measured as follows. Dilutions of
virus were plated on cell monolayers, and the cells were
fixed after 2 days with 0.5% glutaraldehyde in phosphate-
buffered saline for 15 min at room temperature. After being
fixed, the cells were permeabilized by incubation on ice for
10 min in 2 mM MgCI2-0.01% sodium deoxycholate-0.02%
Nonidet P-40. This mixture was then removed and replaced
with the same solution containing 5 mM potassium ferricy-
anide-ferrocyanide plus 5-bromo-4-chloro-3-indolyl-,-D-ga-
lactopyranoside (X-Gal) (1 mg/ml). Plates were counter-
stained with phenol red, and "blue" and "white" plaques
were counted. Appropriate dilutions of transfection progeny
were then plated, and after 3 days, recombinant plaques
were detected by using an overlay of 1% low-melting-
temperature agarose containing X-Gal (300 ,ug/ml). Blue
plaques were picked, subjected to two further rounds of
plating and plaque picking, and finally cloned by limiting
dilution.
Construction of HSV-1 A5Z. For the competition binding
experiments described in the Results section, it was conve-
nient to use a virus which expressed P-galactosidase but was
of wild-type phenotype in vitro. The Us5 coding sequence
has been shown to be dispensable in vitro (50) and was
therefore used as an insertion site for the lacZ gene. An AccI
fragment (nucleotides Us 3704 to 6591 [37]) containing the
UsS gene was cloned into the AccI site of pBR322 (nucleo-
tides 651 to 2244), and a synthetic polylinker was inserted
into the SstI site within the UsS gene (nucleotide Us 5337).
The HindlIl insert of plasmid pMV10 was then excised, end
repaired, gel purified, and inserted into the EcoRV site of the
polylinker. A plasmid was chosen in which the reading
direction of the lacZ insert corresponded to the reading
direction of the UsS gene. This plasmid was then cotrans-
fected into BHK cells with HSV-1 (SC16) DNA, and a
recombinant, 3-galactosidase-positive virus was selected
and cloned from the transfection progeny as described
above. The genotype of the virus was confirmed by Southern
blotting and found to contain the expected lacZ coding
sequences, driven by the CMV IE-1 promoter, within Us5.
This virus plaqued normally and had particle-infectivity
ratios indistinguishable from those of the parent virus.
Enzyme assays. Monolayers of 5 x 104 infected cells were
washed once with 100 mM sodium phosphate-10 mM
KCl-10 mM MgCI2-50 mM 2-mercaptoethanol and lysed in
200 pd of the same buffer containing 1% Triton X-100.
Lysates were stored at -70°C. P-Galactosidase assays were
performed by addition of o-nitrophenyl-3-D-galactopyrano-
side (ONPG) to thawed lysate to a final concentration of 6
mM. The increase in A420 was measured over a period of 2 h
at room temperature. Thymidine kinase assays were per-
formed as described by Klemperer et al. (29).
Other methods. HSV-1 and recombinant virus derived
from it were purified from the tissue culture medium and the
cytoplasm of infected cells as described previously (11).
Particle numbers were estimated by comparison with latex
beads (approximately 250 nm in diameter) of known concen-
tration by the "loop drop" method (49). All particle numbers
refer to enveloped particles. The methods used for Southern
blotting and Western immunoblotting have been described
previously (11).
RESULTS
Rationale for generating a gH- mutant of HSV-1. Our
objective was to engineer an HSV-1 mutant in which gH
coding sequences were replaced by lacZ coding sequences
under the control of a constitutive promoter, the IE-1
promoter of human CMV, generating a virus that could be
identified by virtue of its ability to synthesize 3-galactosi-
dase. Since previous data indicate that gH is required for
virion infectivity (11), we predicted that propogation of a
deletion mutant would require a cell line capable of supply-
ing gH in trans. Although a cell line constitutively expressing
gH has been described (16), our own attempts to express gH
have suggested that constitutive expression of gH at ade-
quate levels would be cytotoxic (21). Our strategy was
therefore to establish a cell line containing a gH gene under
the control of an HSV-1-specific promoter so that gH would
be expressed only after infection with HSV. However, since
gH is a late gene (24, 46), the gH promoter itself is unlikely
to be suitable for this purpose because a late promoter
resident in the cell genome is likely to be subject to shut-
down by HSV-1 infection. This problem was avoided by
introducing a gH coding sequence into cells under the
control of the gD-1 promoter. A similar strategy has been
used to achieve inducible expression of HSV gC (43).
Generation of a cell line inducible for gH-1 expression.
Plasmid pAF2 (see Materials and Methods) was digested
with HindIlI and partially digested with EcoRI to generate a
3.8-kb fragment which contained the gH-coding sequence of
HSV-1 strain HFEM flanked by 5' and 3' untranslated
sequences of the Xenopus P-globin transcript. This fragment
was ligated with Hindlll- and EcoRI-digested pgDBr (13, 14)
to place the gD-1 promoter (bases -392 to +11) upstream of
the gH-coding sequences. The resulting plasmid was named
pgDBrgH (see Fig. 2).
Subconfluent monolayers of Vero cells were cotransfected
with pgDBrgH and pSV2Neo (47), and after 2 days, the cells
were harvested, transferred to 96-well microtiter trays, and
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FIG. 1. Induction of gH-1 synthesis by HSV-2 infection of Vero
cells transfected with the HSV-1 gH gene. Vero cells or cloned cell
lines transfected with the gH-1 gene as described in the text were
infected with HSV-2 at an MOI of 5 (+) or left uninfected (-). After
16 h, the cells were harvested, the lysates were subjected to
SDS-PAGE, and the products were transferred to nitrocellulose.
HSV-1 gH was detected by using antiserum to a TrypE-gHI fusion
protein. The track marked HFEM contained a lysate of Vero cells
infected with HSV-1 (HFEM) at an MOI of 5. All tracks contain a
lysate derived from approximately 5 x 10 cells. pgH, high mannose
precursor of gH (11).
grown in medium containin'g G418. After 15 days, surviving
colonies were harvested, plated in duplicate 24-well trays,
and grown to confluence (-2 x 105 cells per well) in medium
containing G418. One set of cultures was then infected with
HSV-2 at an MOI of 5, and after 16 h, the infected cells were
harvested, lysates were subjected to sodium dodecyl sulfate
(SDS)-polyacrylamide gel electrophoresis (PAGE), and the
products were transferred to nitrocellulose. Lysates contain-
ing HSV-1-specific gH were identified by using antiserum to
a TrypE-gH fusion protein (11). Among 136 cultures, 5 were
found to synthesize gH-1 following infection with HSV-2,
and these cultures were cloned by limiting dilution. Cloned
cells were again subjected to HSV-2 infection and Western
blotting with TrypE-gH antiserum.
The results obtained with two clones from different cul-
tures are shown in Fig. 1. Both clones produced gH-1 in
response to HSV-2 infection, but neither contained detect-
able gH when uninfected, and both clones produced substan-
tially more gH-1 than equivalent numbers of HSV-1-infected
Vero cells. No gH was detected in HSV-2-infected Vero
cells, confirming the specificity of the antiserum for HSV-1
gH. DNA was extracted from both cell lines and subjected to
EcoRI digestion. The digestion products were examined by
Southern hybridization with a probe composed ofgH coding
sequences flanked by ,B-globin untranslated transcript se-
quences (from pAF2). The results (Fig. 2) indicate a high
copy number of gH coding sequences, considerably in
excess of 10 copies per cell and probably close to 100 copies
per cell. The majority of the hybridization signal was asso-
ciated with fragments of 3.7 and 2.9 kb, corresponding to the
fragments generated by EcoRI digestion of the transfection
plasmid pgDBRgH, implying that the transfected cells con-
tain large head-to-tail concatemers of the input plasmid. This
was not investigated further. The F6B2 cell line was used in
all subsequent work and is hereafter called F6. The high
levels of gH made upon infection of the F6 cell line (by
comparison with HSV-1 infection of Vero cells) probably
reflect both the high DNA copy number and the fact that the
gene is driven by the relatively strong gD promoter.
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FIG. 2. DNA was extracted from Vero cells and from trans-
fected cell lines. The DNA was digested with EcoRI and subjected
to gel electrophoresis and Southern blotting. The filters were hy-
bridized with the BgII fragment derived from pAF2. (a) Track 1,
Vero cells; track 2, F6 cells; track 3, B1.1 cells; tracks 4 and 5, DNA
from neomycin-resistant clones that did not yield gH-1 on infection
with HSV-2. Track 6 is a positive control containing Vero cell DNA
plus pgDBrgH DNA equivalent to approximately 10 copies per cell.
The exposure time for track 6 was eight times longer than for the
remaining tracks. (b) Positions of the EcoRI sites in pgDBrgH, the
plasmid used for transfection, and the region covered by the probe.
for supplying gH in trans to a gH-deficient HSV-1 mutant.
However, it was conceivable that the very high level of
expression of gH achieved following infection and the fact
that expression of gH from the gD promoter would occur
earlier in the growth cycle than in a standard HSV infection
might be incompatible with efficient HSV replication. To
reassure ourselves on this point before proceeding with
production of a null mutant, the ts mutant tsQ26, which is
nonpermissive at 39°C by virtue of a mutation in gH, was
plated at 39°C on Vero cells or F6 cells. The parental virus,
HSV-1 strain KOS, was also plated as a control. tsQ26
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FIG. 3. Ability of F6 cells to support the growth of mutant tsQ26. Monolayers of Vero cells (panels 1 and 2) or F6 cells (panels 3 and 4)
were infected at low MOI with HSV-1 KOS (panels 2 and 4) or tsQ26 (panels 1 and 3), and the monolayers were incubated for 2 days at 39°C.
Monolayers were then fixed and stained. Panels show examples of individual plaques.
cells produced large plaques that were indistinguishable
from those produced by the parent virus. Figure 3 shows that
both KOS and tsQ26 produced syncytial plaques on F6 cells,
although both viruses are nonsyncytial on Vero cells, sug-
gesting that the early expression or high-level expression of
gH is capable of conferring the syncytial phenotype.
Production of gH null mutant. The BgIII m fragment of
HSV-1 HFEM (bases 41429 to 47860 [35]) was cloned into
the BamHI site of pAT153, and the majority of the gH-
coding sequences were removed by digestion with PvuII
(bases 44960 to 46070) and religation to form pATAgH. A
3.8-kb lacZ cassette was obtained from pMV10 by Hindlll
digestion and gel purification. This fragment, which contains
the lacZ gene flanked by the promoter and poly(A) addition
site of the CMV IE-1 gene, was end-repaired with Klenow
fragment and inserted into the PvuII site of pATAgH to
generate pJAM2. Restriction analysis of pJAM2 indicated
that the lacZ gene was oriented in the same direction as the
interrupted gH gene. Since the CMV IE-1 promoter (bases
-299 to +69 in pMV10) contains translation termination
codons in all reading frames, a transcript derived from the
gH promoter in pJAM2 would be translated to give the first
104 residues (including the signal peptide) of gH and would
terminate soon thereafter in the CMV IE-1 promoter se-
quence.
BHK-21 cells were cotransfected with HSV-1 strain SC16
DNA and pJAM2 DNA. After two days, when the monolay-
ers exhibited extensive cytopathic effect, the cultures were
harvested, sonicated, and replated on monolayers of F6
cells. After 2 days, the monolayers were overlaid with 1%
agarose in medium containing X-Gal, and P-galactosidase-
positive plaques were picked and subjected to two further
rounds of plaque picking, followed by cloning by limiting
dilution. Southern hybridization of one cloned virus con-
firmed that the gH coding sequences had been replaced by
the lacZ cassette (Fig. 4), and this virus, named SCgHZ, was
used in subsequent experiments. This virus failed to form
plaques on Vero cells (the relative plaquing efficiency on
Vero cells compared with that on F6 cells was less than
10-5). SCgHZ is derived from strain SC16, whereas the
complementary cell line, F6, was constructed by using a gH
coding sequence derived from strain HFEM because conve-
nient cloned DNA was available. SCgHZ grown in F6 cells
will not, therefore, be phenotypically identical to the parent
virus, SC16. However, we do not think that this raises
problems because we have found no electrophoretic or
antigenic difference between the gHs of HFEM and SC16
and the two proteins differ in amino acid sequence at only
three positions (18).
Properties of SCgHZ. In order to prepare SCgHZ virions
lacking gH, 108 Vero cells were infected with SCgHZ at an
MOI of 3, and after 1 h for adsorption, nonadsorbed virus
was neutralized with antibody LP2 (ascitic fluid diluted 1:200
in medium). The antibody was replaced with fresh medium
after 30 min, and the cells were harvested and sonicated after
24 h. Electron microscopic examination revealed that the
numbers of virus particles and the proportions of enveloped
and naked particles were similar to those in a stock of
wild-type SC16 virus made in parallel in Vero cells under the
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FIG. 4. DNA samples from F6 cells infected with
(lanes 2 and 4) or from Vero cells infected with HS
digested with BstEII (lanes 1 and 2) or with BamHI
and subjected to agarose gel electrophoresis and So
to nitrocellulose. The filters were hybridized with 32P
comprising (a) the 2.57-kb BstEII subfragment of an
clone or (b) the 3.07-kb lacZ coding sequence deri
digestion of pMV10. Positions of the relevant rest
HSV-1 DNA and in SCgHZ are shown below. p(
addition site; PIE-1, CMV IE-1 promoter.
tive virions were capable of initiating infecti
wild-type virus (SC16), SCgHZ grown on I
SCgHZ grown on Vero cells were assayed on n
F6 cells, and the results were expressed as
enveloped virus particles. Table 1 shows that
PFU ratios of wild-type virus and SCgHZ virus
TABLE 1. Rescue of infectivity of gH-negati
by using PEG
PFL
Virus (cells") gH gH ogenotype phenotype Witho
PEG
HSV-1 SC16 (Vero) gH+ gH+ 8.5 x
SCgHZ (F6) gH- gH+ 9.2 x
SCgHZ (Vero) gH- gH- <10'
a Cell type used for virus propagation.
b Particle counts were performed on crude virus stocks, al
were plated on monolayers (5 x 10i cells) of F6 cells. Parti
to enveloped particles.
I An inoculum comprising approximately 108 enveloped pa
plaques.
cells were indistinguishable. Thus, the F6 cell line compen-
sates fully for the genetic defect in SCgHZ. Phenotypically
gH-negative virions (SCgHZ virus grown on Vero cells)
yielded no plaques at the highest concentration used, con-
firming that gH is absolutely required for virion infectivity
(11). When the monolayers were treated with 50% (wt/wt)
polyethylene glycol (PEG) after virus adsorption as de-
-~526kb scribed by Sarmiento et al. (44), the numbers of plaques
formed by wild-type virus or by SCgHZ (gH+) virus were
_3 n7kb unchanged. However, this treatment resulted in the partial
-~07kb recovery of infectivity by gH-negative virions. This result
can be interpreted to mean that gH-negative virions will bind
to the cell surface but that membrane fusion, a process that
can be achieved artificially with PEG, fails to occur. This
interpretation is consistent with that of Fuller et al. (17), who
found that virions neutralized with anti-gH antibody bound
to the cell surface but failed to penetrate. The results
obtained by using PEG fusion should be interpreted with
caution because the recovery of infectivity is low. Never-
theless, the results with gH-negative virions are quantita-
tively similar to those obtained with gB-negative and gD-
negative virions (5, 32), implying that all three types of
virions attach equally well to the cell surface.
The nature of the interaction of a mutant virus with the cell
surface can be examined by determining whether adsorption
of mutant virions will block infection by wild-type virions.
BstE This rationale has been used by Johnson and Ligas (26) to
<&&Q show that gD-negative virions, despite their ability to bind,
will not block entry by superinfecting virus, a result which
they interpreted to mean that gD binds to a saturable
receptor. We therefore performed similar experiments with
HSV-1 SCgHZ gH-negative virions. Different concentrations of blocking
V-1 SC16 were virions (wild type, gD negative, and gH negative) were
(lanes 3 and 4) added to monolayers of BHK-21 cells in 96-well trays and
outhern transfer allowed to adsorb for 2 h at 4°C. Nonabsorbed virus was
'-labeled probes removed by washing with three changes of medium, and
HSV-1 Bglll-m wild-type virus was added at an MOI of 5. After a further 2
ved by BamHl h at 4°C, nonadsorbed virus was removed by washing andtriction sites in the temperature was raised to 37°C to allow penetration. In
oly A, poly(A) these experiments, the wild-type virus (i.e., gD+ gH+) used
for blocking was a thymidine kinase deletion mutant
(TKDM21). The superinfecting virus was SC16A5Z, which is
on, stocks of thymidine kinase positive and carries a lacZ gene driven byon6 clls, and the CMV IE-1 promoter. Infection by superinfecting virus6ncells, and could therefore be measured by thymidine kinase and ,-ga-
npoFnolayeers Of lactosidase activities. Note that both the gD-negative and
the prticl gH-negative blocking virions also contain lacZ genes, but in
g oneF6rticle/ preliminary experiments these viruses induced no P-galac-i grown on F6 tosidase activity even at the highest concentrations used for
blocking, either in the absence of a superinfecting wild-type
virus or following infection by a lacZ-negative wild-type
ve virions virus. Thus, gD- and gH- viruses are entirely unable to
enter cells and cannot be "helped" to enter cells by wild-
J/109 particles type virions.
on F6 cells" Initial experiments were performed with TK- P-Gal-
ut (TKDM21) blocking virions and TK+ P-gal+ (SC16A5Z)
tuWith PEG superinfecting virions. Cultures were harvested 4 h after the
temperature was raised to 37°C and assayed for thymidine106 7.6 x 106 kinase and 3-galactosidase. It is apparent from Fig. 5A that106 5.5 x 106 different results are obtained by assaying different activities.3.2 x 10 When infection by superinfecting virus is measured by
thymidine kinase activity, the observed effect of blocking
nd serial dilutions virions is greater than that observed when ,B-galactosidase
cle numbers refer activity is measured. Thymidine kinase activity induced by
articles yielded no superinfecting virus is virtually abolished by 104 blocking
particles, a result close to that obtained by Johnson and
VOL. 66, 1992
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FIG. 5. Monolayers of BU-BHK (TK-) cells in 96-well trays (approximately 5 x 104 cells per well) were inoculated with various numbers
of purified TKDM21 particles (TK- wild type [WT]). gD-negative particles (FgD-P), or gH-negative particles (SCgHZ). Virus was allowed
to adsorb for 2 h at 4°C, the inoculum was removed, and the monolayer was washed three times with cold medium. Monolayers were then
inoculated with 10 PFU of HSV-1 A5Z (wild-type virus expressing the lacZ gene and positive for thymidine kinase) per cell. After adsorption
for 2 h at 4°C, the inoculum was removed and replaced with medium at 37°C, and the monolayers were incubated for 4 h at 37°C. Extracts
were then prepared and assayed for thymidine kinase or ,3-galactosidase. (A) Results of thymidine kinase assays and 3-galactosidase assays
from monolayers blocked with TKDM21 and infected with HSV-1 A5Z. (B) Results of P-galactosidase assays from monolayers blocked with
different particle types and infected with HSV-1 A5Z. In panel B, WT refers to TKDM21, the same virus used for blocking in panel A.
Ligas (26). Considerably larger numbers of blocking parti-
cles are required to achieve equal reduction of induced
,3-galactosidase activity. One obvious interpretation of these
results is that, since thymidine kinase is synthesized as a
delayed early protein, its synthesis will be sensitive to
factors in addition to those which affect cell surface block-
ing. For example, since TKDM21 blocking particles enter
cells when the temperature is raised, competition for virus-
specific transcription factors may occur. Whatever the rea-
son, it seemed that ,B-galactosidase was the more relevant
assay to use in these experiments because this gene was
controlled by the CMV IE-1 promoter: it should therefore be
expressed at immediate-early times and independently of
virus-specific transcription factors.
The relative abilities of gD+ gH+ virions (TKDM21), gD-
virions, and gH- virions to block superinfecting virus is
shown in Fig. 5B. We found, as reported by Johnson and
Ligas (26), that gD- virions fail to block superinfecting
virus, while wild-type virus does so efficiently. Johnson and
Ligas interpreted this result to indicate that gD binds to a
saturable receptor, and this view is supported by the fact
that soluble gD will also block infection (25). However, it is
apparent that gH- virions block superinfection much less
efficiently than wild-type virus. A number of explanations
are possible: for example, it is conceivable that gD is
absolutely required for saturation of a cell surface receptor
but that this interaction is less efficient in the absence of gH.
A much simpler explanation is that the blocking effects of
normal virions involve multiple mechanisms. The designs of
the experiments described here and of those performed by
Johnson and Ligas (26) inevitably result in the entry of the
blocking (wild-type) virions when the culture temperature is
raised. These virions will then compete in all processes
required to initiate infection: transport of the nucleocapsid to
the nucleus, entry into the nucleus, and transcription of the
viral genome. This reasoning implies that, in experiments of
this type, the "blocking" effects of wild-type virions cannot
be interpreted solely in terms of saturation of cell surface
receptors. Since gH- virions do not enter cells, the blocking
effect of these virions is presumably due to effects at the cell
surface alone.
DISCUSSION
It has been assumed for several years that gH of HSV-1
performs an essential function in vitro because mutations
within the gH coding sequence have been shown to be lethal
or conditionally lethal (7, 11, 34). In this article, we formally
confirm this assumption by showing that deletion of gH
coding sequences is lethal and can be fully compensated for
by providing gH in trans. Previous data have implied that gH
is required for virion infectivity (11), and the results pre-
sented here confirm this view. Virions lacking gH cannot
initiate plaque formation in gH-positive cells, and even when
used at an MOI of 105 enveloped particles per cell, no virus
entry was detected, as judged by expression of the lacZ gene
resident in gH- virions. Whether gH functions in processes
other than virion infectivity is uncertain. Infection of Vero
cells with genotypically gH- virions resulted in the produc-
tion of progeny virions in numbers similar to those observed
in parallel wild-type infections, and the proportion of envel-
oped particles was unaltered. However, a detailed biochem-
ical analysis of the gH- virions has not been done. The
ability of gH antibodies to inhibit virus spread (1, 20)
suggests that gH is involved in interactions between the
plasma membranes of infected and uninfected cells, and the
behavior of different antibody-resistant mutants implies that
these functions of gH, in virion infectivity and intercellular
transmission, may not be identical (18).
gH is conserved among members of all the herpesvirus
subgroups, and in the case of Epstein-Barr virus, we can be
confident that gp85 (the homolog of HSV-1 gH) does not
function as a receptor-binding protein because this function
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binding to CR2 on B cells (15, 40). A priori, then, we would
predict that gH of HSV-1 is not responsible for receptor
binding, though this prediction assumes a common function
for gH in all herpesviruses. Our results support this view.
First, the defect in gH-negative virions can be overcome in
part by achieving membrane fusion with PEG, and second,
gH- virions will block adsorption of superinfecting wild-
type virions. Both results imply that gH- virions bind to
cells but fail to enter and hence that gH operates in mem-
brane fusion. Nevertheless, these results should be inter-
preted with caution. Induction of membrane fusion with
PEG rescues only a small fraction of infectivity, and similar
results have been attained with gB- and gD- virions (5, 32),
implying that none of the known essential glycoproteins of
HSV-1 is required for adsorption and that all three are
required for membrane fusion. WuDunn and Spear (51) have
shown that the adsorption of HSV-1 virions to cell surfaces
is mediated by interactions with cell surface heparin sulfate.
It seems unlikely that gB, gD, or gH is involved in this
interaction, because virions lacking each of these glycopro-
teins will adsorb to cells. Pseudorabies virus also adsorbs to
heparin sulfate, and in this case the protein involved is
apparently gpIII, a dispensable glycoprotein and the ho-
molog of HSV-1 gC (38, 45). It is uncertain whether HSV-1
gC is a heparin-binding protein, but it has been noted that
gC- virions adsorb more slowly than wild-type virions (31).
Johnson et al. (25) take the view that the accumulation of
virus particles at the cell surface by interaction with heparin
sulfate is followed by the interaction of the virus with a
saturable receptor in the plasma membrane and that gD is
absolutely required for this indispensable step (but not for
heparin binding) because gD- virions will bind to cells but
will not block superinfecting wild-type virus (26) and be-
cause soluble gD will block infection (25). We confirm the
result of Johnson and Ligas (26) that gD- virions will not
block entry of superinfecting virus, whereas we find that
gH- virions will not enter cells but will block adsorption of
wild-type virus. The simplest interpretation is that gH func-
tions after gD in the entry process, presumably in membrane
fusion. However, this interpretation must be qualified by the
fact that gH- virions blocked superinfection less efficiently
than gH+ virions. We consider that this is best explained by
the fact that wild-type virions can interfere with infection by
competing virus particles at several points in the infection
process in addition to receptor binding, but this is difficult to
quantify, and at present we cannot rule out the possibility
that gH is involved in receptor binding.
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